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Increasing the thermostability of proteins is often crucial for their successful use as analytic, synthetic or
therapeutic tools. Most rational thermostabilization strategies were developed on small two-state proteins
and, unsurprisingly, they tend to fail when applied to the much more abundant, larger, non-fully
cooperative proteins.We show that the key to stabilize the latter is to know the regions of lower stability. To
prove it, we have engineered apoflavodoxin, a non-fully cooperative protein on which previous
thermostabilizing attempts had failed. We use a step-wise combination of structure-based,
rationally-designed, stabilizing mutations confined to the less stable structural region, and obtain variants
that, according to their van’t Hoff to calorimetric enthalpy ratios, exhibit fully-cooperative thermal
unfolding with a melting temperature of 756C, 32 degrees above the lower melting temperature of the
non-cooperative wild type protein. The ideas introduced heremay also be useful for the thermostabilization
of complex proteins through formulation or using specific stabilizing ligands (e.g. pharmacological
chaperones).
P
roteins are important analytic, synthetic and therapeutic tools1–3. Controlling the stability of proteins is
crucial for their successful manufacture, storage, combination, administration and, in general, for their use
ex vivo or in vivo (www.nist.gov/mml/bmd/biomanufacturing.cfm). The concept of protein stability may
refer to different things, such as stability towards chemical alteration4, kinetic stability towards transformation
into non-native conformations5,6, or the thermodynamic stability of the native form, which is governed by the
equilibrium constant with the ensemble of denatured conformations7,8. In many cases, increasing the conforma-
tional stability of a protein is beneficial as it brings concomitant increases in kinetic stability or chemical stability.
A primary synthetic tool for protein stabilization is mutagenesis, which can be implemented in directed evolution
methods based in generating diversity and selecting the more stable variants9,10, or through rational design of
specific mutations, often based in analysis of the protein three-dimensional structure and in understanding the
interactions governing protein folding11,12. Many rational strategies have been developed to stabilize proteins,
including a-helix stabilization13, charge optimization14,15, cavity filling16,17, disulfide bond engineering18,19,
replacement of hydrophobic external residues20,21 or of polar buried residues22, neutralization of hydrogen
bonds23, denatured state entropy reduction24, or structure-guided consensus25,26. Although, admittedly, any
specific mutation based on any of those strategies may fail, implementation of several such mutations in a given
protein is expected to yield in most cases a more stable variant.
For convenience, the development and testing of rational protein stabilization strategies has heavily relied in
the engineering of small model proteins of less than 200 residues and typically displaying simple two-state
unfolding equilibria towards denaturant-induced unfolding or towards thermal denaturation27,28. In this endea-
vor, the chief design principle has consisted in introducing amino acid replacements that either lower the enthalpy
of the native state relative to the denatured one, or lower the entropy of the denatured state relative to the native
one, on the assumption that the denatured state is essentially unstructured and devoid of the interactions
observed in the native structure. However, small proteins constitute a small fraction of proteomes. According
to the 01-Oct-14 release of UniProt/SwissProt (http://web.expasy.org/docs/relnotes/relstat.html) the average
protein length is 355 residues. Proteins of that size are expected to deviate from the two-state behavior and to
populate partly unfolded conformations in addition to the native and fully unfolded ones. Examples of three-
state unfolding equilibria abound even among small, one-domain proteins (e.g. in the thermal unfolding of
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149-residue staphylococcal nuclease mutants29, in 104-residue onco-
nase30 or in 169-residue apoflavodoxin31). In general, non-fully coop-
erative proteins will contain at least two structural regions of
different stability that will often unfold sequentially (Figure 1). In
many cases, the unfolding of the less stable region will signal the loss
of the biological activity, and the population of a partly unfolded
intermediate that may be prone to aggregation. For that majority
of large proteins that are unlikely to display full unfolding coopera-
tivity, using the common strategies of rational design without pre-
vious identification of the less stable region may be very
disappointing15. The reason is that, unlike for denatured states, the
structure of equilibrium intermediates cannot be easily anticipated,
and assuming homogeneously unstructured intermediates is not
realistic.
The apoflavodoxin from Anabaena PCC 7119 is a small 169-
residue, monodomain protein displaying two-state urea denatura-
tion and a three-state thermal unfolding31,32. Its thermal intermediate
is characterized by a severe loss of native structure at the FMN
cofactor binding site33–35 and it is considered, for this reason, to be
non-functional. At 25.0uC, in native conditions, the thermal inter-
mediate represents around 7% of the protein population35.
Therefore, apoflavodoxin can be considered a three-state protein.
Previous attempts to rationally increase its thermostability by intro-
ducing charge reversal mutations that had greatly increased the glo-
bal conformational stability at 25uC unexpectedly failed because the
design had ignored the intrinsic complexity of non-two state pro-
teins15. After having delineated through experimental33–35 and com-
putational work36 the two stability regions of this protein, we show
here how a complex protein can be thermostabilized by specifically
administering rational strategies to its less stable region. By a step-
wise combination of rationally designed individual stabilizing muta-
tions we have increased the lower melting temperature of the protein
by 32 degrees and converted it from three-state to a fully cooperative
two-state protein, according to its van’t Hoff to calorimetric enthalpy
ratio.
Experimental section
Design of mutants. All mutants have been designed from inspection and analysis of
the x-ray structure of wild type (WT) apoflavodoxin37 from Anabaena PCC 7119
(pbd id 1ftg) and the solution structure34 of the F98N apoflavodoxin mutant (pbd id
2kqu), which closely corresponds to the structure of the partly unfolded
apoflavodoxin thermal intermediate33–36 (Figure 2).
Apoflavodoxin contains two structural regions of different stability33. Eleven single
stabilizing mutations (Table 1) have been designed in the less stable region or at the
interface of the two regions with the aim of specifically increasing the lower melting
temperature: T1. The rationale behind the mutations is the following:
Figure 1 | Unfolding equilibria of a three-state protein. (A) Ribbon cartoons representing the conformation of apoflavodoxin in the three states
populated in its thermal unfolding equilibrium. The native state in represented by the crystal structure of theWT protein (pdb id: 1ftg); the intermediate
state by the solution structure of the F98N variant (pbd id: 2kqu), and the unfolded state by one of the 2000 conformations calculated for the unfolded
ensemble using the ProtSA server. The low temperature transition (T1) signals the unfolding of the less stable region leading to an equilibrium
intermediate. The higher temperature transition (T2) represents the unfolding of the intermediate, leading to the unfolded state. The free energy
difference between the native and the intermediate conformation (DGNI) is termed relevant stability of the protein while that between the intermediate
and the fully unfolded conformation (DGIU) is termed residual stability of the protein. (B) Simplified scheme depicting a protein with two structural
regions of different stability (less stable region in cyan, and more stable one in pink) and the likely effects of mutations on T1 and T2. Type 1 mutations,
those introduced in the unstable region or at its interface with the more stable one, will mainly modify the relevant stability of the protein. Type 2
mutations, those introduced in the more stable region, will only modify the residual stability of the protein.
www.nature.com/scientificreports
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. I59A and I92A: replacement of highly exposed hydrophobic residues by shorter
ones. The ProtSA server38 was used to identify those residues as highly exposed in
the native structure. Ile59 is more exposed in the native state than in the unfolded
ensemble, while Ile92 is similarly exposed in either state.
. Q99A and R155L: replacement of poorly exposed, polar neutral or charged resi-
dues by non polar ones. The ProtSA server38 was used to identify those residues by
the low solvent exposure of their polar or charged side chain atoms in the folded
state (0 and 8 A˚2, respectively).
. E61K and D126K: replacement of negatively charged residues in proximity
to other negative charges by positively charged residues so that electro-
static repulsion in the native state is decreased. The electrostatic unfavor-
able interactions of Glu61 and Asp126 were calculated using electrostatic
simulations14,15.
. D100N: replacement of a hydrogen bonded aspartate residue by a neutral, isos-
teric asparagine one. The stabilizing effect of converting charged hydrogen bonds
into neutral ones was previously reported23.
Figure 2 | Ribbon diagrams showing the structure of native apoflavodoxin (pdb id: 1ftg) (A) and that of the apoflavodoxin thermal unfolding
intermediate (B), represented by the solution structure of the F98N apoflavodoxin mutant (pbd id: 2kqu; model 1). The residues of the less stable
structural region or at the interface between the two regions that have been mutated in order to increase the relevant stability of the protein are shown in
sticks representation. As can be seen (panel B), those residues appear in disordered, exposed to solvent regions of the thermal unfolding intermediate.
Table 1 | Thermal unfolding of apoflavodoxin variants: wild type (WT) and mutants thereof
Protein variant DHNI (kcal/mol) TmNI (uC) DHIU (kcal/mol) TmIU (uC)
WT 34.7 6 2.0 42.8 6 0.3 55.6 6 2.0 55.1 6 0.4
I59A 47.2 6 0.1 50.1 6 0.1 50.2 6 0.5 55.3 6 0.1
E61K 41.0 6 0.9 47.8 6 0.1 38.0 6 1.0 58.6 6 0.2
G87V 38.8 6 0.7 51.1 6 0.7 52.8 6 2.3 61.1 6 0.3
I92A 29.7 6 6.9 50.5 6 1.5 38.9 6 2.9 53.2 6 0.8
Q99A 52.1 6 0.6 49.4 6 0.1 56.2 6 1.2 58.3 6 0.4
D100N 47.0 6 1.8 51.6 6 0.5 53.3 6 6.9 58.6 6 0.9
S121P 33.4 6 0.4 45.4 6 0.3 64.1 6 1.7 56.6 6 0.1
D126K 40.6 6 0.2 48.8 6 0.2 45.1 6 1.3 57.7 6 0.1
S129A 40.7 6 1.3 49.2 6 0.2 48.8 6 2.2 58.6 6 0.3
A142V 33.6 6 3.3 46.9 6 0.7 57.3 6 5.3 57.5 6 0.6
R155L 34.3 6 2.3 50.3 6 0.9 42.4 6 3.7 55.2 6 0.7
E20Ka 30.2 6 0.3 42.7 6 0.4 66.1 6 1.3 59.7 6 0.1
E72Ka 33.2 6 0.2 45.4 6 0.3 57.8 6 1.0 63.1 6 0.1
I92A/I59A 34.3 6 3.1 49.4 6 1.0 61.6 6 3.8 56.5 6 0.7
I92A/D100N 48.3 6 4.3 50.1 6 0.6 60.1 6 3.8 58.0 6 0.6
I92A/A142V 40.4 6 2.8 54.1 6 1.7 48.1 6 3.2 63.2 6 3.8
A142V/I59A 36.4 6 2.9 53.8 6 0.8 61.6 6 6.3 62.0 6 0.8
A142V/G87V 37.4 6 2.0 56.8 6 0.6 42.4 6 3.3 67.9 6 1.5
A142V/D100N 39.4 6 2.0 56.0 6 0.5 47.3 6 3.4 62.9 6 0.5
aMutations at the stable structural region. From Campos et. al, 200415.
www.nature.com/scientificreports
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. G87V and A142V: replacement of small residues located near a small protein
cavity by bulkier ones so that the cavity is filled, with gain in van der Waals
interactions and hydrophobic effect. This strategy was successfully tested prev-
iously in other cavities of the same protein17.
. S121P andD129A: replacement of two solvent exposed residues by residuesmore
frequent in structurally equivalent positions of homologous flavodoxins. This
consensus strategy has been reported to be effective in other proteins25,26.
On the other hand, two charge reversal mutations located in the stable flavodoxin
region (E20K, E72K), and previously reported to specifically increase the higher
melting temperature of the protein: T215, have now been combined with mutation
D126K (located at the less stable region, see above) to construct a triple mutant,
termed 3M, which is significantly more stable thanWT apoflavodoxin. BothWT and
3M apoflavodoxins have been used as starting points to test the feasibility of intro-
ducing and combining stabilizing mutations at the two stability regions in order to
rationally push the lower melting temperature of this three-state protein towards
higher values. The specific stabilizing mutations and combinations introduced and
tested are described in Tables 1 and 2.
Mutagenesis, protein expression, purification, and spectroscopic characterization
by circular dichroism. All mutated flavodoxin genes were synthesized by site-direct
mutagenesis using the Mutagenex Inc company service (www.mutagenex.com). The
sequence of some of the mutated genes, randomly selected, was verified by additional
sequencing using different primers, and always coincided with the reported one (not
shown). Mutated genes were introduced in the pTrc99A plasmid39 and expressed in
BL21 E. coli cells as described40. The flavodoxin variants were purified by combining
ammonium sulfate precipitation with ionic exchange in DEAE sepharose, and the
corresponding apoflavodoxins were obtained by removal of the FMN cofactor by
TCA precipitation of the protein moiety, as described32.
Circular dichroism (CD) spectra were recorded at 25.0 6 0.1uC in a thermostated
Chirascan apparatus from Applied Photophysics. Near-UV CD spectra were
recorded from 260 to 310 nm using 20 mM protein solutions dissolved in 50 mM
MOPS buffer, pH 7.0 with a 1-cm path length cuvette. Far-UV CD spectra were
recorded from 200 to 250 nm with protein solutions of the same concentration
dissolved in 5 mM MOPS buffer, pH 7.0 with 15 mM NaCl and a 1-mm cuvette.
Thermal denaturation by absorbance, fluorescence and far-UV and near-UV CD,
and their global analysis.Apoflavodoxin displays a three-state thermal denaturation
mechanism according to both spectroscopic and calorimetric analysis15,31,33. The
three-state model used and the assumptions made to analyze the apoflavodoxin
thermal unfolding data has been recently reviewed in detail8. Briefly, the spectroscopy
signal of a family of thermal unfolding curves corresponding to the same protein
variant and recorded using different spectroscopic techniques is globally fitted to
equation (1)
S~
SUzSIe{DGUI=RTzSNe{ DGUIzDGINð Þ=RT
1ze{DGUI=RTze{ DGUIzDGINð Þ=RT
ð1Þ
where S is the protein signal at a given temperature (T), SU, SI and SN are the signals of
protein solutions of equal concentration of either unfolded, intermediate or native
protein respectively, and DGUI and DGIN are the free energy differences of the
equilibria between the unfolded and intermediate conformations (residual stability)
or between the intermediate and the native conformation (relevant stability). Those
free energies are approximated by the integrated Gibbs-Helmholtz equation:
DG~DHTm 1{T=Tmð Þ{DCp Tm{TzT ln T=Tmð Þ½  ð2Þ
where Tm, DH and DCp are the melting temperature, enthalpy change and heat
capacity change of the specific equilibrium.
The thermostability of forty apoflavodoxin variants has been determined in
50 mMMOPS, pH 7.0 as follows. For each variant, four unfolding curves in 50 mM
MOPS, pH 7.0, from approximately 8 to 94uC, were monitored by far-UV CD
(222 nm; 20 mMprotein, 1-mm path length), near-UV CD and near-UV absorbance
(290 nm; 20 mMprotein, 4-mmpath length) and fluorescence emission (excitation at
280 nm; ratio of 320/360 nm emission; 2 mM protein). Although, using fluorescence
emission ratios to minimize the effect of temperature in curve baselines is not gen-
erally advised8, the inaccuracy introduced in individual Tms is minimized when
differences in Tm values (DTm) are calculated41. The four unfolding curves obtained
for each variant were roughly normalized between 0 and 1 and then globally fitted to a
three-state equation using Origin 8.0 (OriginLab Corporation) and MLAB software
(Civilized software). The global fitting of the four curves provides, for each mutant
protein, a single set of DH1, T1, DCp1, DH2, T2, and DCp2 values plus specific sets of
spectroscopic parameters for each curve8,33. The melting temperatures (T1 and T2)
and enthalpy changes (DH1 andDH2) corresponding to the two unfolding transitions
of each mutant are reported in Table 1 (WT series) and Table 2 (3M series). The
values obtained in global spectroscopic fits for the changes in heat capacity of the
transitions are not accurate42 and will not be reported. Discrimination between two-
and three-state models was performed based on the: 1) visual inspection of fitting
analysis (fits and residuals); and 2) comparison of the chi-square values. Only variants
whose set of unfolding curves were not superimposable (i.e. did not provide essen-
tially the same Tm and DH values when individually analyzed) were subjected to
three-state analysis.
Thermal denaturation by differential scanning calorimetry (DSC). The DH1, T1,
DCp1, DH2, T2, and DCp2 values of wild-type and apoflavodoxin mutants were also
measured with a high-precision differential scanning VP-DSC microcalorimeter
(MicroCal LLC, Northampton, MA). All samples were degassed and loaded into the
cells, avoiding bubble formation. The heat capacity of apoflavodoxin wasmeasured as
Table 2 | Thermal unfolding of apoflavodoxin variants: 3M (WT plus E20K/E72K/D126K) and mutants thereof
Global spectroscopic three-state fit DSC two-state fit
Protein variant
DHNI
(kcal/mol) TmNI (uC)
DHIU
(kcal/mol) TmIU (uC)
DHND
(kcal/mol) TmND (uC)
DHVHa
(kcal/mol)
DHVH
DHND
3Mb 38.3 6 2.8 50.0 6 0.4 71.9 6 2.4 66.7 6 0.2 83.4 6 0.2 67.7 6 0.1 70.9 6 0.3 0.85
3M/I59A 37.2 6 1.1 57.6 6 0.2 87.6 6 2.4 68.0 6 0.2 - -
3M/E61K 40.9 6 0.2 55.0 6 0.1 83.6 6 2.3 67.3 6 0.8 - -
3M/G87V 40.1 6 1.2 58.8 6 0.2 80.2 6 0.4 68.8 6 0.1 - -
3M/I92A 34.2 6 2.0 50.6 6 3.1 65.8 6 0.7 65.1 6 1.6 - -
3M/Q99A 47.9 6 0.6 58.3 6 0.1 81.9 6 1.8 68.6 6 0.1 - -
3M/D100N 49.1 6 3.2 68.0 6 0.1 95.9 6 1.7 69.7 6 1.1 71.4 6 0.2 69.2 6 0.1 67.0 6 0.3 0.94
3M/S121P 40.8 6 0.1 56.2 6 0.1 75.3 6 1.1 68.6 6 0.1 - -
3M/D129A 55.1 6 0.9 60.7 6 0.3 83.4 6 1.1 68.1 6 0.1 - -
3M/A142V 19.7 6 2.1 66.0 6 4.7 83.7 6 2.8 68.2 6 0.4 72.1 6 0.2 69.4 6 0.1 75.4 6 0.2 1.05
3M/I92A/I59A 46.5 6 1.8 63.9 6 0.3 73.7 6 2.0 69.9 6 0.8 - -
3M/I92A/G87V 52.4 6 6.6 58.9 6 1.8 37.1 6 3.3 75.1 6 9.5 - -
3M/I92A/D100N 46.5 6 2.2 63.2 6 0.6 96.9 6 6.2 69.3 6 0.5 - -
3M/I92A/A142V 43.6 6 2.9 59.0 6 0.8 56.5 6 6.9 67.3 6 1.9 - -
3M/A142V/G87V - - - - 76.7 6 0.1 74.4 6 0.1 79.8 6 0.2 1.04
3M/A142V/D100N - - - - 82.0 6 0.1 70.4 6 0.1 83.6 6 0.2 1.02
3M/A142V/G87V/I92A - - - - 79.1 6 0.1 74.9 6 0.1 75.9 6 0.2 0.96
3M/A142V/I92A/D100N - - - - 82.3 6 0.1 70.6 6 0.1 85.6 6 0.2 1.04
3M/A142V/I92A/I59A - - - - 87.6 6 0.1 70.3 6 0.1 92.9 6 0.2 1.06
3M/A142V/G87V/D100N - - - - 84.6 6 0.1 74.9 6 0.1 84.5 6 0.2 1.00
WTb 84.4 6 0.2 55.8 6 0.1 51.5 6 0.2 0.61
aVan’t Hoff enthalpies,DHVH, have been determined by DSC, assuming a two-state protein unfolding mechanism, using the known equation:DHVH~
4RT2mCp,max
DHND
, where Tm is the mid-transition temperature,
Cp,max is the maximal value of the excess molar unfolding heat capacity, and DHND is the calorimetric enthalpy. If the assumed two-state unfolding model is correct the calorimetric enthalpy, DHND, and the
van’t Hoff enthalpy, DHVH are equal (i.e. DHVH/DHND 5 1.0). Otherwise, both enthalpies are significantly different.
bThe DHVH/DHND ratio of mutant 3M indicates its thermal unfolding is not two-state. The same applies to the WT protein included in this Table for comparison.
www.nature.com/scientificreports
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a function of temperature. The baseline of the instrument was recorded before the
experiments with both cells filled with buffer. Thermal denaturation scans, from 10 to
110uC, were performed using 40 mMprotein solutions in 50 mMMOPS, pH 7.0 with
a scanning rate of 1 uC/min. DSC data analysis was performed by using a two-state or
a three-state model43,44 implemented in the Origin 7.0 software package.
Discrimination between two- and three-state models was performed based on the: 1)
visual inspection of fitting analysis (fits and residuals); 2) comparison of the chi-
square values; and 3) comparison of the van’t Hoff and calorimetric enthalpies.
Chemical denaturation and data analysis. Protein solutions were prepared mixing
900-mL urea solutions (from 0 M to 7.2 M) with 100 mL of 20 mM apoprotein
solutions in 500 mM MOPS, pH 7.032. All samples were equilibrated at 25uC for
30 min. Protein unfolding was followed by fluorescence emission at 320 nm with
excitation at 280 nm (25.0 6 0.1uC) using a thermostated Cary Eclipse Fluorescence
Spectrophotometer. Apoflavodoxin urea unfolding follows a simple two-state
mechanism32. Thus, the curves were analyzed by the linear extrapolation method45
using a two-state equation implemented in Origin 8.0 (Origin Lab Corporation),
essentially as described17.
Calculation of stability differences: relevant and residual stabilization. The
difference in stability between a wild type protein and amutant thereof (DGwt-DGmut)
is best calculated using the following simplified equation8,46 that holds in the
proximity of the transition temperature of WT:
DDG~DGwt Twtm
 
{DGmut Twtm
 
<{DHmut Tmutm
 
1{Twtm

Tmutm
  ð3Þ
For a three-state thermal unfolding equilibrium (N«I«U) such as that of apo-
flavodoxin31, the global stability of the protein (DGNU) is divided in two terms:
DGNU~DGNIzDGIU ð4Þ
where DGNI represents the ‘‘relevant’’ stability of the native state relative to the
intermediate54 while DGIU is the ‘‘residual stability’’ of the intermediate relative to the
fully unfolded state. The term ‘‘relevant stability’’ has been chosen to indicate that the
intermediate in non-functional, as suggested by the disruption of the cofactor binding
site33–35. Comparison of wild type and mutant three-state proteins allows to calculate
the changes brought about by a given mutation in both the relevant and the residual
stabilities (DDGNI~DG
wt
NI{DG
mut
NI ; DDGIU~DG
wt
IU{DG
mut
IU . In the proximity of
Twt1 , the temperature characterizing the N-to-I transition, the change in relevant
stability can be approximated as:
DDGNI~{DH
mut
NI T
mut
1
 
1{ Twt1

Tmut1
   ð5Þ
A negative value of the free energy variations defined in equation 5 indicates that the
mutant is more thermostable than the wild type protein (or the appropriate reference
protein) for the indicated transition.
Results and Discussion
Why complex proteins are more difficult to stabilize rationally
than two-state proteins. Early protein stability studies showed47 that
the native three-dimensional structure of many proteins coexists, in
thermodynamic equilibrium, with a vast number of unstructured,
fluctuating conformations known as the unfolded state or, more
modernly, unfolded ensemble. This observation inspired the two-
state model (N«U) so widely used to quantify the stability of
proteins42.
A two-state unfolding equilibrium indicates that the native struc-
ture is stabilized in a highly cooperative manner, the cooperativity
arising from mutual strengthening of pairwise interactions due to
entropic effects48. Although the unfolding equilibrium ofmany small
proteins can indeed be described by the two-state model49, examples
abound of more complex proteins that, at moderate concentrations
of denaturant or solution temperatures, populate intermediate con-
formations at equilibrium with the native and unfolded states30,50–53.
Given the average size of proteins, non-two state unfolding might be
in fact much more common than two-state. The simplest case of a
non-two-state equilibrium is that of monomeric, three-state proteins
with two transitions (N«I«U), each characterized by a free energy
difference and a specific melting temperature. For those proteins, the
global conformational stability (DGNU) is made of two terms
(Equation 4): DGNI, which has been termed the relevant stability of
the protein to indicate that the thermal intermediate is not expected
to remain functional, and DGIU, the residual stability of the partly
unfolded intermediate54. In two-state proteins, global and relevant
stability mean the same because there is no residual stability.
Determining the stability of three-state proteins with approaches
adapted from those applied to two-state ones is a fairly easy task,
although it may involve acquiringmore experimental data. However,
stabilizing three-state proteins using the rational synthetic strategies
developed over the years for thermostabilization of two-state
proteins is not so easy. In fact, it poses a specific difficulty that needs
to be understood in order to minimize failures.
Clearly, if the goal is to increase the thermal stability of a three-
state protein, one should concentrate in increasing T1, the temper-
ature at which half of the molecules remain folded and half adopt the
conformation of the intermediate, rather than in increasing T2, the
melting temperature of the already partly unfolded intermediate
(Figure 1). Our early work in stabilization of the model protein apo-
flavodoxin (a single domain protein exhibiting two-state urea dena-
turation and three-state thermal unfolding)31,32 showed that many
rationally designed mutations that successfully increased the overall
stability of the protein (DGNU) failed to increase T1. Instead, most of
the stabilization emerged as higher values of T215. In practice, those
apoflavodoxin variants were more stable than wild type at 25uC but
not more thermostable because their T1 values were the same. This
paradox can be explained by the lower cooperativity exhibited by
three-state proteins compared to two-state ones. Structural analysis
of the apoflavodoxin equilibrium intermediate revealed that it retains
the native conformation in approximately two thirds of the structure,
while the other third is unfolded33. Thus, the single folding domain of
the protein is divided into two stability structural regions: a large one
with a greater thermostability governed by T2, and a smaller one that
becomes unfolded at the lower temperature T1. All stabilizing muta-
tions located in the larger,more stable region failed to increaseT1 and
only increased the thermostability of the intermediate towards full
unfolding. Conversely, all the stabilizingmutations located in the less
stable region did increase T1, as initially intended15. The reason why
complex proteins are more difficult to stabilize rationally than two-
state ones is thus quite simple: if the less stable structural region is not
known in advance, the probability that a designed mutation locates
by chance at themore stable, larger structural region is high. Based in
these observations we hypothesize that the specific increasing ofT1 in
order to raise the relevant stability of a three-state protein requires
specific intervention at the less stable structural region.
Rational, specific stabilization of each of the two apoflavodoxin
stability structural regions. Previous experimental work based on
equilibrium phi-analysis andNMR33,34 established that the less stable
region of apoflavodoxin comprises segments 87-108 and 118-172,
which are in contact in the three-dimensional structure. More
recently, fast computational calculation of the apoflavodoxin
regions exhibiting poor packing densities and forming highly polar
interfaces (LIP regions55) identified essentially the same segments as
those constituting the less stable regions of the protein. Thus, to
prove our hypothesis, we have designed 11 potentially stabilizing
mutations (see Experimental Section) involving residues at this less
stable region of apoflavodoxin or at the interface between the two
regions (Figure 2). The mutations selected are inspired by different
rational strategies developed for two-state proteins over the years by
our group and many others. They include shortening of highly
exposed hydrophobic residues, replacement of poorly exposed
polar or charged residues by neutral ones, improvement of
electrostatic interactions, isosteric neutralization of hydrogen
bonds, cavity filling, and replacement by more frequent residues in
structurally equivalent positions. These mutations, individually or in
different combinations, have been implemented in the wild type gene
to produce forty apoflavodoxin variants (Tables 1 and 2) obtained
with yields (4–8 mg/L) similar to those of the wild type protein
(6 mg/L). To check whether the mutations alter the secondary or
tertiary structure of the proteins, far-UV and near-UV CD spectra
have been recorded (Figure 3). The far UV-CD spectra of the wild
www.nature.com/scientificreports
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type series and those of mutants based on 3M apoflavodoxin (see
below) are similar to those of the corresponding reference protein,
although some mutants display differences at the 208 nm minima.
On the other hand, the near-UV CD spectrum of apoflavodoxin is
characterized by three peaks arising from tryptophan residues in the
native environment that disappear when the protein is unfolded by
denaturants or heat32. All the variants display the near-UV CD
spectrum of natively folded apoflavodoxin. The CD data thus
indicate that no large structural rearrangements have occurred in
the 40 variants. Besides, the mutants exhibit enthalpy changes for
the unfolding equilibria that are similar to those of theWT protein or
of the 3M variant, (Tables 1 and 2), which also suggests the mutants
retain the original tridimensional structure of apoflavodoxin.
The thermal unfolding curves of the WT protein are shown in
Figure 4A. In agreement with our hypothesis, the 11 individual single
mutants of the wild type protein present (Table 1 and Figure 5A)
increased T1 values (from 2.6 to 8.8uC) relative to WT (average DT1
5 6.4uC). Also in agreement with our hypothesis, their T2 values
were not generally increased relative to WT. Instead, one mutant
displayed a lower T2, two mutants displayed essentially the same
T2 as WT, seven mutants showed modest increases and only one
mutant showed a significant increase (average DT2 5 2.2uC). The
feasibility of specifically increasing T1 in three-state proteins by
introducing common types of stabilizing mutations in the less stable
region of the protein or at its interface with the stable region is thus
clearly demonstrated.
On the other hand, the fact that introducing stabilizing mutations
in the stable region of the protein only serves to increase T2 had been
amply demonstrated in previous work using charge reversal muta-
tions15. Indeed, the four more successful such mutations, E20K,
E40K, E72K andD75K, lead to averageDT2 5 5.2uCwith a negligible
effect in the relevant stability (average DT1 5 0.1uC; Figure 5C). We
have combined two of thesemutations at the stable region (E20K and
E72K, Table 1) with mutation D126K at the less stable one to build a
second reference protein termed 3M apoflavodoxin. 3M apoflavo-
doxin displays a CD spectrum and an enthalpy change for the first
Figure 3 | Near-UV Circular Dichroism (A, C) and far-UV Circular Dichroism (B, D) spectra of wild-type and mutants thereof (A, B) and of the 3M
variant and mutants thereof (C, D) recorded at 25.06 0.16C in 50 mMMOPS buffer, pH 7.0 (near-UV spectra) or 5 mMMOPS buffer, pH 7.0 with
15 mM NaCl (far-UV spectra).
www.nature.com/scientificreports
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unfolding equilibrium (DH1) similar to those of WT apoflavodoxin
(Figure 3 and Table 2) while its DH2 is larger, as expected from its
higher T2. Therefore, the overall structures of the 3M and of the WT
reference proteins are likely similar. Relative to WT, 3M display a
moderately increasedT1 (by 7.2uC) and an even greater increase inT2
(by 11.6uC). These increases in melting temperature values are close
to accumulative of the individual effects exerted in WT by the three
mutations in 3M. As a consequence, the temperature gap (T2–T1) is
larger in 3M than in WT, which offers more room for increasing the
relevant stability (Table 2). 3M apoflavodoxin thus allows to retest in
the context of a more stable protein whether specific stabilization of
the less stable region is the way to specifically increasing T1. Nine of
the individual mutations tested in WT (see above) have also been
introduced in 3M (Table 2) and their stabilizing effects have been
determined (Table 2). Once again, in agreement with our hypothesis,
all 3M-based single mutant proteins but one (3M/I92A) present
significantly increased T1 values (from 5.0 to 18.0uC) relative to
3M (average DT1 5 9.0uC; Figure 5B) while their T2 values are only
slightly higher than that of 3M (average DT2 5 1.3uC).
Additivity of mutations. Rationally designed mutations, such as
those introduced in this work, tend to yield moderate increases in
Tm values. The single mutations tested on the less stable region of
either WT or 3M apoflavodoxin have each increased the T1 of the
corresponding reference protein by 6–8uC. If their effects could be
accumulated, larger thermostabilizations would be feasible. We first
tried accumulating increases in T1 on the WT/92A mutant scaffold
but only one out of three single point mutations added (mutantWT/
92A/142V) significantly increased T1 (Table 1). Thus, we tried
increasing T1 from WT/142V. Besides 92A, three other mutations:
59A, 87V or 100N were individually introduced on WT/142V
(Table 1). In this case, the increases in T1 brought about by those
four mutations on the WT/142V protein were similar to those
previously observed on WT (DT1 5 7.7, 7.3, 8.3 or 8.8uC,
respectively in WT versus 7.2, 6.9, 9.9, or 9.1uC on the already
stabilized WT/142V). Therefore, each of those four variants
accumulated the increase in T1 caused by mutation 142V (4.1uC)
with those of the particular additional mutation, elevating the WT
T1 of 42.8 to around 55uC. At the same time, the accumulation of
stabilizing mutations in the less stable region begun to significantly
increase the stability of the stable domain, so that the four variants
exhibited T2 values around 64uC, well above the T2 of 55.1uC inWT.
To assess whether a much more stable apoflavodoxin variant
could similarly benefit from accumulative stabilization of T1, we also
combined T1-increasing mutations on 3M (table 2). As with WT, we
first tried accumulating mutations on the 3M/92A variant. Four T1
stabilizing point mutations were tested (59A, 87V, 100N and 142V)
and all of them further increased T1 by an average of 10.7uC, quite
similar to their average stabilizing effect of 12.6uC previously
observed on 3M.We also tried accumulatingmutations on a different
3M scaffold: 3M/142V. In addition to the 92A mutation already
discussed, two other mutations (87V and 100N) were individually
added to such a scaffold. In either case, the stabilization achieved was
very large and a change from three-state to two-state unfolding
behavior was observed (Table 2). On average, the six variants dis-
cussed, each accumulating two stabilizing mutations on 3M, raised
T1 from 50.0uC in 3M to around 65.0uC. In these six variants, the
stabilization of the second transition was smaller, as expected, but
significant: from a T2 of 66.7uC in 3M to an average of 71.1uC. It
seems clear that the relevant stability of both WT and of its more
stable 3M version can be easily increased by accumulating the T1-
increasing effects of individual mutations.
Thermostabilization versus global stabilization determined by
chemical denaturation. Chemical denaturation plus LEM
analysis42 is a common way to accurately determine folding free
energy differences (i.e. protein thermodynamic stability) at a given
temperature below that of thermal denaturation. Using chemical
denaturation, the difference in stability of protein variants can be
readily obtained. One question here is whether chemical
denaturation constitutes a reliable guide for the rational
thermostabilization of complex proteins, and there are at least two
reasons why it is not. The first reason, already explained, is that some
proteins exhibit two-state chemical denaturation but three-state
thermal denaturation. In such proteins an increase in the overall
stability detected in chemical denaturation can translate into just
an increase in the residual stability of the intermediate (DGIU) and
leave the relevant stability of the native state (DGNI) unchanged. The
second reason, that protein stability is a complex function of
temperature, applies even when the stabilizing mutation is
specifically introduced in the less stable region of a three-state
protein. To illustrate these facts, we have determined by urea
denaturation the global stability at 25.0uC of some of the
flavodoxin variants described above (Figure 6 and Tables 3 and 4).
While many of the point mutants of theWT and of the 3M reference
apoflavodoxins displaying either an increased T1 or T2 are indeed
more stable towards the full two-state unfolding (N-to-U) at 25uC
probed by chemical denaturation (Tables 3 and 4; Figure 6), some
Figure 4 | Thermal unfolding of three-state wild type apoflavodoxin
(A) and of one thermostabilized two-state apoflavodoxin variant 3M/
A142V/G87V/D100N (B) followed by near-UV CD (black), near-UV
absorbance (red), far-UV CD (blue) and emission fluorescence (cyan).
The curves are shown roughly normalized to signal spans from 0 to 1 and
do not represent fractions of folded protein. For each protein, the global fit
of the four curves to a three-state (WT) or a two-state model is represented
by the continuous lines.
www.nature.com/scientificreports
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others are not more stable or are even less stable. The discrepancy is
particularly noticeable for the more thermostable 3M-based
mutants. These results illustrate that although thermostabilization
often converts into a greater stability at lower temperatures, selecting
mutants for their greater stability at a low temperature is not a
reliable criterion to guide rational thermostabilization.
From three-state to two-state unfolding as the relevant stability is
increased. The spectroscopic and thermodynamic properties of WT
apoflavodoxin make the global fitting of several thermal unfolding
curves monitored using different spectroscopic techniques the best
way to accurately determine the two melting temperatures of its
three-state equilibrium15. Due to the low enthalpy change of the
first unfolding transition, accurate determination of T1 by
differential scanning calorimetry (DSC) is difficult. Still, DSC is the
best way to unequivocally determine, from a comparison of the van’t
Hoff and calorimetric enthalpies56, whether the thermal unfolding of
a specific flavodoxin variant retains the three-state character of the
WT or has changed to two-state. For this reason the 36 flavodoxin
variants described so far were routinely analyzed by DSC to confirm
that they were indeed three-state mutants. Out of the 36 variants, 32
were clearly three-state. Two possible exceptions were 3M/D100N
and 3M/A142V, for which reasonable two-state DSC fits could be
obtained (Table 2). The apparent two-state behavior of these 3M-
based mutants prompted us to analyze a second round of mutants
introduced into 3M/A142V and we found two more mutants (3M/
Figure 5 | Increases inmelting temperatures (DT1 in cyan andDT2 inmagenta) observed in apoflavodoxin variants bearingmutations at either the less
or the more stable structural region. Individual and average DT1 and DT2 relative to WT (A) or to the 3M variant (B) for mutations located in the less
stable region or at the regions interface. Individual and average DT1 and DT2 relative toWT for mutants located at the more stable region, from Campos
et al, 200415 (C). Ribbon diagram of the intermediate solution structure (pbd id: 2kqu; model 1) depicting in cyan residues mutated at the less stable
region of native apoflavodoxin or, in magenta, at the more stable region, which remains folded in the thermal intermediate.
Figure 6 | Chemical unfolding curves of apoflavodoxin and variants
thereof, followed by fluorescence emission at 320 nm. The curves are
roughly normalized to signal spans from 0 to 1 and do not represent
fractions of folded protein. The solid lines are fits to a two-state equation.
www.nature.com/scientificreports
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A142V/G87V and 3M/A142V/D100N) whose DSC profiles were
best fitted to a simple 2-state unfolding (Table 2). The realization
that, in those four mutants, T1 had been raised to equal their
corresponding T2, made us further combine stabilizing mutations.
Thus, we introduced additional combinations of two stabilizing
mutations (chosen between G87V, D100N, I59A and/or I92A) into
3M/A142V containing scaffolds and obtained four new mutants:
3M/A142V/G87V/I92A, 3M/IA142V/92A/D100N, 3M/A142V/
I59A/I92A and 3M/A142V/G87V/D100N. For those four final
mutants, the DSC thermograms (see Figure 7 for mutant 3M/
A142V/G87V/D100N) clearly indicated that the thermal unfolding
was two-state, with ratios of van’t Hoff and calorimetric enthalpies
between 0.96 and 1.1. Similarly, their spectroscopic curves could be
superimposed and globally fitted to a two-state equation (see
Figure 4B for mutant 3M/A142V/G87V/D100N).
Therefore sufficient accumulations of stabilizing mutations in the
less stable region and/or in its interface with the stable one can in the
end strengthen protein folding cooperativity to the point of trans-
forming a three-state protein into a two state one. The prize is of
course that, in the process, T1 is so much raised that the increase in
the relevant stability is very large. The average single Tm of the last
four two-statemutants discussed is of 72.6uCwhich, compared to the
WT T1 of 42.8uC, means the mutants have increased their relevant
thermostability by 29.9uC. The most stable mutants, 3M/A142V/
G87V/D100N and 3M/I92A/A142V/G87V, with Tm of 74.9uC have
been stabilized by 32.1uC, relative to WT. In terms of free energies,
the increase in the relevant stability of the two more stable mutants
from that of WT can be calculated using eq. 3 to be of around
8 kcal/mol.
Divide and combine: a general strategy for the thermal
stabilization of complex proteins. Based on the above results, we
propose that efficient, relevant thermostabilization of three-state
proteins can be achieved applying a ‘‘divide and combine’’
approach consisting of the following steps:
. 1-Structural delineation of the more stable and less stable regions
(by either experiment33–35 or computation36,55).
. 2-Design, testing and selection of stabilizing mutations involving
substitution of residues at the less stable region or at the interface
between regions: type 1 mutations.
. 3-Design, testing and selection of stabilizing mutations involving
substitution of residues at the stable region: type 2 mutations.
. 4-Combination of type 2 mutations to obtain a scaffold with
higher T2.
. 5-Sequential combination of type 1 mutations on the previous
scaffold.
A simplermethod is possible by omitting steps 3 and 4 and directly
combining type 1 mutations on the wild type protein, but a lower
thermostabilization is to be expected in that case. It should be men-
tioned that, although stabilization of the less stable region may pro-
vide by itself the interface stabilization required to eventually obtain
two-state full cooperative unfolding, a direct intervention including
the introduction of a few stabilizing mutations at the interface seems
Table 3 | Chemical unfolding of apoflavodoxin variants: wild type (WT) and mutants thereofa
Protein variant m (kcal mol21 M21) [urea]m (M) DG (kcal mol21) D[urea]m (M) DDGND (kcal mol21)
WT 2.48 6 0.05 2.07 6 0.01 5.13 6 0.02 - -
I59A 2.50 6 0.08 2.48 6 0.01 6.19 6 0.17 20.40 21.05 6 0.17
D100N 2.26 6 0.14 2.25 6 0.02 5.08 6 0.10 20.18 0.06 6 0.11
A142V 2.47 6 0.14 2.31 6 0.02 5.70 6 0.24 20.23 20.56 6 0.24
I92A 2.06 6 0.10 1.82 6 0.03 3.75 6 0.04 0.25 1.39 6 0.04
E61Kb 2.66 6 0.09 2.24 6 0.01 5.96 6 0.20 20.17 20.83 6 0.20
E20Kb 2.58 6 0.07 2.56 6 0.01 6.60 6 0.18 20.49 21.47 6 0.18
E72Kb 2.40 6 0.13 2.64 6 0.02 6.34 6 0.35 20.57 21.21 6 0.35
D126Kb 2.58 6 0.10 2.35 6 0.01 6.06 6 0.24 20.28 20.93 6 0.24
I92A/I59A 2.30 6 0.09 1.90 6 0.01 4.35 6 0.03 0.18 0.79 6 0.04
I92A/D100N 2.01 6 0.08 1.98 6 0.02 3.98 6 0.01 0.09 1.16 6 0.03
I92A/A142V 1.86 6 0.07 2.06 6 0.02 3.81 6 0.11 0.02 1.32 6 0.12
aThe reported values of m, [urea]m and DG are means of two determinations 6 SE. D[urea]m are differences between WT and mutant. DG are free energy differences of full unfolding (N-to-U) at 25.0uC.
DDGND are differences between WT and mutant with propagated errors.
bFrom Campos et al, 200415.
Table 4 | Chemical unfolding of apoflavodoxin variants: 3M (WT plus E20K/E72K/D126K) and mutants thereofa
Protein variant m (kcal mol21 M21) [urea]m (M) DG (kcal mol21) D[urea]m (M) DDGND (kcal mol21)
3M 2.30 6 0.06 3.68 6 0.01 8.46 6 0.04 --- ---
3M/I92A 1.93 6 0.10 3.31 6 0.02 6.40 6 0.10 0.37 2.06 6 0.11
3M/G87V 2.16 6 0.07 3.86 6 0.01 8.33 6 0.16 20.18 0.14 6 0.16
3M/A142V 2.36 6 0.09 3.84 6 0.01 9.07 6 0.57 20.16 20.60 6 0.57
3M/D100N 2.16 6 0.09 3.60 6 0.02 7.78 6 0.35 0.08 0.69 6 0.35
3M/I92A/G87V 1.76 6 0.07 3.65 6 0.02 6.40 6 0.24 0.04 2.07 6 0.24
3M/I92A/D100N 1.90 6 0.08 3.40 6 0.01 6.46 6 0.01 0.28 2.00 6 0.03
3M/I92A/A142V 2.15 6 0.10 3.68 6 0.02 7.90 6 0.13 0.01 0.56 6 0.13
3M/A142V/G87V 1.68 6 0.06 4.20 6 0.02 7.05 6 0.30 20.52 1.42 6 0.30
3M/A142V/D100N 2.00 6 0.07 3.77 6 0.01 7.53 6 0.29 20.09 0.93 6 0.29
3M/A142V/G87V/D100N 1.88 6 0.04 3.59 6 0.02 6.72 6 0.08 0.10 1.74 6 0.09
3M/I92A/A142V/G87V 1.99 6 0.07 4.16 6 0.02 8.27 6 0.17 20.48 0.20 6 0.17
3M/I92A/A142V/D100N 2.15 6 .070 3.83 6 0.01 8.21 6 0.17 20.15 0.25 6 0.17
3M/I92A/A142V/I59A 2.14 6 0.08 3.78 6 0.01 8.06 6 0.01 20.10 0.41 6 0.02
aThe reported values of m, [urea]m and DG are means of two determinations 6 SE. D[urea]m are differences between WT and mutant. DG are free energy differences of full unfolding (N-to-U) at 25.0uC.
DDGND are differences between WT and mutant with propagated errors.
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advisable. Importantly, when a two-state variant is finally obtained,
the target for thermostabilization is no longer confined to the small,
less stable structural region, and the much larger mutational space of
the entire protein becomes usable to proceed with further stabiliza-
tion though rational design.
We would like to recall that proteins can also be stabilized through
ligand binding, an important emerging field in protein formula-
tion57,58 and in the development of a family of drugs known as phar-
macological chaperones59,60. The underlying ideas of the divide and
combine approach illustrated here with thermostabilization by site-
directed mutagenesis might also be useful for increasing protein
stability through ligand binding in complex proteins. The goal in
that case would be the identification of ligands that specifically bind
to the less stable region of the protein or at its interface with a more
stable one.
In summary, the strategy proposed here is general and it only
requires two things: the protein structure and information about
which region is unfolding first.
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